FALANGA ANNA

Ruolo:

Professore straordinario a tempo determinato

Settore scientifico disciplinare:

MALATTIE DEL SANGUE (MED/15)

Afferenza:

E-mail:

Key, N., Khorana, A., Kuderer, N., Bohlke, K., Lee, A., Arcelus, J., et al. (2020). Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update. JOURNAL OF CLINICAL ONCOLOGY, 38(5), 496-520. Dettaglio
Leader, A., Ten Cate, V., Ten Cate-Hoek, A., Beckers, E., Spectre, G., Giaccherini, C., et al. (2020). Anticoagulation in thrombocytopenic patients with hematological malignancy: A multinational clinical vignette-based experiment. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 77, 86-96. Dettaglio
Poli, D., Antonucci, E., Vignini, E., Martinese, L., Testa, S., Simioni, P., et al. (2020). Anticoagulation resumption after intracranial hemorrhage in patients treated with VKA and DOACs. EUROPEAN JOURNAL OF INTERNAL MEDICINE. Dettaglio
Thachil, J., Tang, N., Gando, S., Falanga, A., Cattaneo, M., Levi, M., et al. (2020). ISTH interim guidance on recognition and management of coagulopathy in COVID-19. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 18(5), 1023-1026. Dettaglio
Thachil, J., Tang, N., Gando, S., Falanga, A., Levi, M., Clark, C., et al. (2020). Type and dose of heparin in Covid-19: Reply. JOURNAL OF THROMBOSIS AND HAEMOSTASIS. Dettaglio

Futuri studenti - Iscrizioni